IEQ Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$950K Sell
51,770
-52,706
-50% -$870K ﹤0.01% 1097
2026
Q2
$1.52M Buy
104,476
+89,089
+579% +$860K 0.01% 927
2026
Q1
$114K Buy
15,387
+310
+2% +$3.26K ﹤0.01% 1781
2025
Q4
$177K Buy
+15,077
New +$163K ﹤0.01% 1712
2025
Q3
– Sell
-25,233
Closed -$184K – 2000
2025
Q2
$184K Buy
+25,233
New +$204K ﹤0.01% 1628

Other funds holding NEO

IEQ Capital's NEO Position: Q3 2026 in Review

IEQ Capital reduced its NeoGenomics (NEO) stake by 50% in Q3 2026, selling an estimated $870K and leaving 51,770 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

IEQ Capital first reported a position in NEO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.52M in Q2 2026. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • IEQ Capital held 51,770 shares of NeoGenomics worth $950K as of Q3 2026.
  • IEQ Capital sold 52,706 NeoGenomics shares in Q3 2026, an estimated $870K.
  • NeoGenomics made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1097 holding.
  • IEQ Capital first reported a position in NeoGenomics in Q2 2025 and has held it in 5 quarters since.
  • IEQ Capital's NeoGenomics position peaked at $1.52M in Q2 2026.
  • 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.